The FDA slapped its highest-risk classification on orthopedic titan Stryker’s (NYSE:SYK) ShapeMatch recall, warning that the devices may not have been manufactured properly.
The issue was picked up via post-market surveillance of product complaints, according to the federal watchdog agency.